| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Age-related differences in unmet needs and their predictors among adults with bladder cancer
|
Scharp, Danielle
|
|
|
43 |
10 |
p. 595.e13-595.e24
|
article
|
| 2 |
An overview of molecular testing in genitourinary malignancies
|
Roy-Chowdhuri, Sinchita
|
|
|
43 |
10 |
p. 533
|
article
|
| 3 |
An RMST-based analysis of systemic therapy in muscle-invasive bladder cancer
|
Venkatesh, Arjun
|
|
|
43 |
10 |
p. 596.e15-596.e21
|
article
|
| 4 |
A population-level analysis on the association of cannabis use and urologic cancers
|
Davis, Ryan J.
|
|
|
43 |
10 |
p. 598.e11-598.e16
|
article
|
| 5 |
Application of RNA sequencing in urologic malignancies: Advances and challenges
|
Al-Obaidy, Khaleel I.
|
|
|
43 |
10 |
p. 544-552
|
article
|
| 6 |
Assessing the uptake of core outcome sets in randomized controlled trials for localized prostate cancer: A cross-sectional study
|
Wright, Carson L.
|
|
|
43 |
10 |
p. 598.e17-598.e24
|
article
|
| 7 |
Assessment of synergistic vs. independent drug activity for enfortumab vedotin and pembrolizumab in untreated advanced urothelial carcinoma
|
Chow, Ryan D.
|
|
|
43 |
10 |
p. 597.e1-597.e4
|
article
|
| 8 |
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations
|
Joffe, Benjamin I.
|
|
|
43 |
10 |
p. 594.e1-594.e7
|
article
|
| 9 |
Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma
|
Ishihara, Hiroki
|
|
|
43 |
10 |
p. 598.e1-598.e10
|
article
|
| 10 |
Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinoma
|
Goodstein, Taylor
|
|
|
43 |
10 |
p. 597.e5-597.e14
|
article
|
| 11 |
Cover 2 - Masthead
|
|
|
|
43 |
10 |
p. IFC
|
article
|
| 12 |
Early real-world utilization of avelumab switch maintenance among patients with advanced urothelial carcinoma without progression following treatment with first-line platinum-based chemotherapy
|
Moon, Helen H.
|
|
|
43 |
10 |
p. 594.e19-594.e29
|
article
|
| 13 |
Editorial Board
|
|
|
|
43 |
10 |
p. i
|
article
|
| 14 |
Enfortumab vedotin-related skin toxicities in patients with urothelial carcinoma: A systematic review and meta-analysis
|
Gazzoni, Gabriela
|
|
|
43 |
10 |
p. 595.e1-595.e11
|
article
|
| 15 |
Featured SUO fellow: Daniel S. Roberson, MD
|
Roberson, Daniel S.
|
|
|
43 |
10 |
p. 585
|
article
|
| 16 |
Genomic profiling of urological malignancies using tissue-based next generation sequencing
|
Alruwaii, Zainab I.
|
|
|
43 |
10 |
p. 534-543
|
article
|
| 17 |
Liquid biopsy testing in urological cancers: Focus on urine
|
Pisapia, Pasquale
|
|
|
43 |
10 |
p. 553-564
|
article
|
| 18 |
Mismatch repair deficiency testing for immune checkpoint inhibitor therapy in genitourinary malignancies
|
Yermakov, Leonid M
|
|
|
43 |
10 |
p. 579-584
|
article
|
| 19 |
Molecular testing in urinary cytology specimens: Current status and future directions
|
Chen, Fei
|
|
|
43 |
10 |
p. 565-578
|
article
|
| 20 |
National trends in diagnoses of subtype histologies in bladder cancer: A population-based study based on the SEER database
|
Wallace, Brendan K.
|
|
|
43 |
10 |
p. 596.e9-596.e13
|
article
|
| 21 |
Sex-based differences in genetic alterations and immune checkpoint inhibitor response in urothelial bladder cancer
|
Kanumuambidi, Jean-Pierre (Trey)
|
|
|
43 |
10 |
p. 594.e9-594.e18
|
article
|
| 22 |
Table of Contents
|
|
|
|
43 |
10 |
p. ii-iii
|
article
|
| 23 |
The impact of prophylactic incisional negative pressure wound therapy on surgical site infection following open radical cystectomy
|
Roberson, Daniel S.
|
|
|
43 |
10 |
p. 586-593
|
article
|
| 24 |
Tumor profiling of advanced urothelial carcinoma: Comparative analysis based on social determinants of health
|
Hart, Lacey J.
|
|
|
43 |
10 |
p. 596.e1-596.e7
|
article
|
| 25 |
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinoma
|
Shapiro, Daniel D.
|
|
|
43 |
10 |
p. 597.e15-597.e23
|
article
|
Journal description